Pharmaceutical solutions & Specialty ingredientsAbout SEQENS in 2022
Our main activities
Events / General
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
The Seqens group has announced today that it has opened a state-of-the-art, 1,500 sqm R&D center in Devens, Mass., to serve as one…Read more
Seqens group at DCAT Week 2023
From March 20 to 23, 2023, a delegation representing all the group’s pharmaceutical activities attended the DCAT week in New York. More than a…Read more
Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.
Back in June 2020, Emmanuel Macron announced his will to restore France’s health sovereignty. Following this, Seqens has chosen to reshore a part of…Read more
Join the Seqens team!
Joining Seqens is a unique opportunity to participate in an exciting growth project with a strong international dimension and a strong entrepreneurial spirit.
Seqens global presenceUse interactive map
Scientists, experts and engineers
Customers in more than 80 countries